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P R E V I E W SXenobiotic metabolism in the
fourth dimension: PARtners in time
A significant portion of the transcriptome in mammals, including the PAR bZIP transcription factors DBP, HLF, and TEF, is
under circadian clock control. In this issue of Cell Metabolism, Gachon and colleagues (Gachon et al., 2006) show that
disruption of these three genes in mice alters gene expression patterns of many proteins involved in drug metabolism
and in liver and kidney responses to xenobiotic agents. Triple mutant mice have severe physiological deficits, including
increased hypersensitivity to xenobiotic agents and premature aging, highlighting the profound effect the circadian clock
has on this important response system.Humans normally only notice their circa-
dian clocks when they are disrupted—
when struggling to stay awake upon
arrival in a new time zone or when trying
to perform optimally at a difficult job
while working the night shift. At these
times, this internal clock seems to be an
inconvenience, making it difficult to func-
tion optimally when out of phase with
one’s environment. However, it has be-
come increasingly clear that circadian
clocks control a vast array of physiologi-
cal functions and behaviors that are crit-
ically important to an organism’s well
being. This has come into sharper focus
in recent years as genetic disruption of
circadian systems has revealed a number
of serious health consequences (Hast-
ings et al., 2003). In this issue of Cell Me-
tabolism, Gachon et al. demonstrate that
loss of three circadian-controlled PAR
bZIP transcription factors in mice causes
disruption of a rhythmic transcriptional
program that regulates circadian detoxi-
fication. The mice exhibit hypersensitivity
to xenobiotic compounds and display
signs of premature aging, providing
a compelling example of the importance
of the circadian system.
Circadian clocks are found in a wide
spectrum of organisms ranging from
cyanobacteria to humans, with many
well-conserved properties (reviewed in
Bell-Pedersen et al., 2005). In mammals,CELL METABOLISM : JULY 2006the circadian oscillator consists of
a core negative feedback loop in which
the transcription factors CLOCK and
BMAL1 activate the Period (Per1, Per2)
and Cryptochrome (Cry1, Cry2) genes
via E box enhancers in their promoters
(Figure 1; reviewed in Lowrey and Taka-
hashi, 2004). The products of these genes
form complexes with each other and with
other proteins and eventually translocate
into the nucleus and repress the CLOCK/
BMAL1 complex, shutting off their own
transcription. This primary negative feed-
back loop is augmented by an interlock-
ing loop in which CLOCK/BMAL1 also
drive transcription of other transcription
factors (REV-ERBa and RORA) that act
to drive rhythmic transcription of the
Bmal1 gene. The circadian mechanism
is cell autonomous, and the majority of
cells and tissues in the body contain cir-
cadian oscillators. At the organismal
level, temporal organization is achieved
by a hierarchical order in which a circa-
dian pacemaker in the suprachiasmatic
nucleus (SCN) synchronizes and co-
ordinates peripheral tissue oscillators
throughout the body (Yoo et al., 2004).
So, how do circadian clocks com-
posed of interlocking feedback loops
control such various output pathways?
Microarray analyses have shown that
w3%–10% of expressed transcripts are
under circadian regulation (reviewed inLowrey and Takahashi, 2004). In the liver,
basic cellular pathways such as glycoly-
sis, fatty-acid metabolism, cholesterol
biosynthesis, and xenobiotic and inter-
mediate metabolism are under circadian
regulation. Importantly, rate-limiting
steps in these various pathways are key
sites of circadian control, highlighting
the fundamental role that circadian
clocks play in cellular and organismal
physiology (Panda et al., 2002). Gachon
et al. provide new insight into the com-
plexities of circadian gene regulatory net-
works using genetic and biochemical
approaches (Gachon et al., 2006). In
this paper, they examine the role of three
PAR-domain basic leucine zipper (PAR
bZip) transcription factors in regulation
of rhythmic gene expression in liver.
One of these proteins, DBP, has defini-
tively been shown by this group to be a
direct transcriptional target of CLOCK/
BMAL1 (Ripperger and Schibler, 2006;
Ripperger et al., 2000). The other two,
TEF and HLF, are reported here to also
be under similar control. These three
proteins can form homo- or heterodimers
and activate transcription of genes con-
taining the appropriate PAR response
element (PARRE).
In order to evaluate how these rhyth-
mic transcription factors contribute to
circadian function, all three PAR bZIP
genes were inactivated by gene targeting3
P R E V I E W Sin mice. The phenotypes of the mice, as
well as all combinations of double knock-
outs, however, were mild. Only after the
heroic effort of generating triple knock-
outs (H2/2/D2/2/T2/2) were strong
phenotypes observed, including epilep-
tic seizures in early life and advanced
aging after 9 months of life (Gachon
et al., 2004).
Because the liver and kidney are the
only tissues known to express all three
transcription factors, the investigators ex-
amined gene expression changes in these
Figure 1. The circadian oscillator drives a cascade
of temporally coordinated rhythmic gene expression
that is necessary for proper response to xenobiotics
The core circadian oscillator mechanism (top) is
composed of two interlocking loops that produce
rhythmic activity of the heterodimeric transcription
factor composed of CLOCK (C) and BMAL1 (B).
CLOCK and BMAL1 drive rhythmic gene expression
of ‘‘output’’ genes, including those encoding the
PAR bZIP transcription factors DBP (D), HLF (H),
and TEF (T). The latter form homo- and hetero-
dimers and activate other genes rhythmically, in-
cluding ones involved in the response to
xenobiotics. These proteins drive expression of de-
toxification genes, including several cytochrome
P450s (CYPs), sulfotransferases (SULT), carboxyl-
esterase (CES), and others (center box). In addition,
these transcription factors also regulate genes en-
coding a retinoid receptor (CAR) that regulates de-
toxification genes in a xenobiotic-inducible manner
(right box) and genes encoding enzymes (ALAS1
and POR) involved in providing heme and electrons
important for the activation of cytochrome P450s
(right box). The net result of this cascade is the ap-
propriately timed production of the many proteins
needed for xenobiotic responsiveness as repre-
sented in the graph (bottom).4tissues in the triple knockout mice. After
profiling liver and kidney mRNAs, they dis-
covered that many of the genes that were
downregulated in the triple knockouts en-
coded proteins that are involved in metab-
olism of xenobiotic agents. These include
genes encoding members of the cyto-
chrome P450 family (Cyp4a,Cyp2c), a nu-
clear receptor (constitutive adrostane re-
ceptor; CAR) that senses xenobiotic
compounds and activates transcription
of several detoxification enzymes, sulfo-
transferases, and drug transporter family
members, among others (Figure 1).
Interestingly, the differentially ex-
pressed mRNAs had a range of profiles,
with some of them normally rhythmic (but
with various phases and amplitudes) and
some of them normally constitutive. They
also were affected to varying degrees by
the loss of the three transcription factors.
Some of the genes had profiles that were
consistent with direct activation by HLF/
DBP/TEF, and two of these genes (Ces3
andAK3l1) were shown to contain PARRE
sequences in their promoters that bound
PAR transcription factors in vitro. How-
ever, a number of other mRNAs had pro-
files that were incompatible with direct
regulation by these proteins, suggesting
that both direct and indirect regulation
were involved in the generation of this
complex pattern of gene expression.
Finally, the functional relevance of the
xenobiotic gene profile differences was
tested in vivo by challenging the triple
knockouts with pentobarbitol and chemo-
therapeutic agents. The wild-type mice
showed pronounced circadian rhythms
in response to pentobarbitol, with much
faster clearance at night than in the day,
while the triple knockout mice had severe
deficits in clearance of the pentobarbitol
at all times of day. Likewise, two chemo-
therapeutic agents (mitoxantrone and cy-
clophosphamide) had increased toxicity
in the triple knockout animals. Interest-
ingly, an increase in morbidity to cyclo-
phosphamide has also been found in
Clock and Bmal1 mutant mice, providing
another circadian connection (Gorba-
cheva et al., 2005). Because Dbp, Tef,
and Hlf are targets of CLOCK and
BMAL1, these PAR bZIP proteins provide
a potential causative link.
Despite the assumption for several de-
cades that circadian modulation of the
pharmacokinetic properties of therapeutic
agents should be physiologically signifi-
cant,direct evidencehas rarelybeenavail-
able. The results by Gachon et al. providean important example of the fundamental
role that circadian clocks play at the cellu-
lar and metabolic level and highlight their
dire consequences when disrupted at
the organismal level. A deeper under-
standing of circadian detoxification mech-
anisms provides a rational basis for opti-
mizing the efficacy of pharmaceutical
agents whose toxicity and side effects
should be reduced by delivery at optimal
times of day. Perhaps one day, both the
timing and dose of drug administration
will become routine in clinical practice.
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